This was the stock's fourth consecutive day of gains.

Abbott Laboratories (ABT) is currently at $138.45, up $5.19 or 3.89% --Would be highest close since March 3, 2025, when it closed at $140.22 --On pace for largest percent increase since Jan. 23, 2025, ...

Illinois-based Abbott Laboratories required job applicants to disclose their family medical histories in violation of the state’s Genetic Information Privacy Act, a proposed federal class action said.

Most readers would already know that Abbott Laboratories' (NYSE:ABT) stock increased by 5.3% over the past three months. Since the market usually pay for a company’s long-term financial health, we ...

A whistleblower’s False Claims Act suit filed in 2021 alleging fraudulent diabetic supplies billing by Arriva Medical LLC, ...

Gov. Greg Abbott is moving Texas closer to legalizing recreational marijuana, but his proposal for regulating its active ...

ABT rides on strong global demand in diagnostics and diabetes care, but macro headwinds may test its momentum ahead.

Shares of Abbott Laboratories (NYSE:ABT) and DexCom (NASDAQ:DXCM) traded higher on Tuesday after Secretary of the U.S.

Abbott Laboratories flexes its market muscle with consistent gains and an enviable track record of long-term growth. Its ...

Greg Abbott has said that "significant uncertainty" over federal funding for SNAP means that Texas will not proceed with the ...

Some of the proposed laws rejected by Abbott, including a ban on hemp products containing THC, will be the focus of a special ...

New Mexico's Homeland Security and Emergency Management requested the assistance following heavy rain and wildfires.